OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?

I gave my HomeExchange guest a 5-star review. Then I found heat marks all over my dining table. Do I call her out?

Inside the push to weaken Washington’s toughest financial watchdog

Scared to spend your retirement money? Here’s one way to get over the fear of running out.

It’s ‘unavoidable’: Apple says it will be forced to raise prices due to the AI boom

Did Warsh and Vance just open the door to higher inflation?

Historic NBA Finals ratings and Fox’s $22 billion Roku deal show live sports are key to winning the streaming wars

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

CVS Health raises 2020 earnings guidance as plan to offer wide range of medical services pays off

November 6, 2020

CVS reported a better-than-expected 3.5% jump in third-quarter revenue, as its plan to remake the drugstore chain into a health service company paid off. Read...

3rdPartyFeeds

Dow Jones Today, Futures Pare Losses On Hiring Surprise; Home Depot, Salesforce.com Get New Buy Points

November 6, 2020

Pennymac Financial was an IBD 50 leader, but stock futures and the Dow Jones today lay low ahead of the October payrolls report. Read More...

3rdPartyFeeds

Amazon a ‘friend’ to department store giant Kohl’s: Michelle Gass

November 6, 2020

Kohl's CEO Michelle Gass joins 'Influencers with Andy Serwer' to discuss her company's strategic partnership with Amazon. Read More...

3rdPartyFeeds

2 Top Robinhood Stocks to Buy in November

November 6, 2020

Commission-free trading platform Robinhood is an excellent heatmap of where retail investors are putting their money. Virgin Galactic is a mid-cap company that...

3rdPartyFeeds • News

Signs point to FDA approval for Biogen’s experimental Alzheimer’s disease treatment, though there are skeptics

November 6, 2020

Odds are increasing that Biogen’s experimental and somewhat controversial Alzheimer’s disease drug may get approved after Food and Drug Administration...

3rdPartyFeeds • News

: RSA’s $9.2 billion takeover offer fails to convince investors

November 6, 2020

All-cash 685 pence a share bid from Canada’s Intact and Denmark’s Tryg would see one of the FTSE 100’s oldest companies broken up

Read More...

3rdPartyFeeds

Dow Jones Futures: Apple, Microsoft Flash Buy Signals In Strong Stock Market Rally; 7 Key Earnings Movers

November 6, 2020

Apple, Microsoft are flashing buy signals as the stock market rally fuels a breakout wave. Square leads earnings movers late. Read More...

3rdPartyFeeds

These 3 Value Stocks Are Absurdly Cheap Right Now

November 6, 2020

To be fair, Wells Fargo (NYSE: WFC) is cheap for a reason. The bank is well capitalized and should emerge from the pandemic in good shape. Ryman Hospitality...

3rdPartyFeeds

2 Best Cannabis Stocks to Own in 2020

November 6, 2020

These Canadian and U.S. pot stocks are trading for wildly different valuations today, but both are setting themselves up for success in the new year. Read More...

3rdPartyFeeds

Facebook shuts dozens of Myanmar pages over ‘inauthentic behaviour’

November 6, 2020

Facebook said on Friday it dismantled dozens of accounts and pages run in Myanmar by commercial operators because of what it described as inauthentic...

Previous 1 … 5,385 5,386 5,387 5,388 5,389 … 8,455 Next
Indices by TradingView

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.